✦ LIBER ✦

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer

✍ Scribed by Jason Konner; Russell J. Schilder; Felicia A. DeRosa; Scott R. Gerst; William P. Tew; Paul J. Sabbatini; Martee L. Hensley; David R. Spriggs; Carol A. Aghajanian

Book ID: 113961602
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 226 KB
Volume: 110
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2008.04.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of outpatient first-lin

A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer

✍ J.P. MICHA; B.H. GOLDSTEIN; M.A. RETTENMAIER; M. GENESEN; C. GRAHAM; K. BADER; K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Pilot study of outpatient paclitaxel, ca

Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer

✍ John P. Micha; Bram H. Goldstein; Mark A. Rettenmaier; Julie Mattison; Cheri Gra 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A phase II study of modified dose-dense

A phase II study of modified dose-dense paclitaxel and every 4 week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma

✍ L. Abaid; J. Micha; M. Rettenmaier; J. Brown; A. Mendivil; K. Lopez; B. Goldstei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A phase II study of GM-CSF and rIFN-γ1b

A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

✍ Kathleen M. Schmeler; Saroj Vadhan-Raj; Pedro T. Ramirez; Sachin M. Apte; Lorenz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 402 KB

A phase II evaluation of nanoparticle, a

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

✍ Robert L. Coleman; William E. Brady; D. Scott McMeekin; Peter G. Rose; John T. S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 214 KB

A phase II evaluation of belinostat and

A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: A gynecologic oncology group study

✍ Don S. Dizon; John A. Blessing; Richard T. Penson; Richard D. Drake; Joan L. Wal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 197 KB